Your browser doesn't support javascript.
loading
Basal cell carcinoma of the prostate: a case report of a rare prostate cancer and review of the literature.
Puglisi, Silvia; Cremante, Malvina; Rescigno, Pasquale; Gandini, Annalice; Zanardi, Elisa; Fornarini, Giuseppe; Rebuzzi, Sara Elena.
Afiliação
  • Puglisi S; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. silvia.puglisi95@gmail.com.
  • Cremante M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. malvina.cremante@gmail.com.
  • Rescigno P; Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle Upon Tyne, United Kingdom. pasquale.Rescigno@newcastle.ac.uk.
  • Gandini A; a:1:{s:5:"en_US";s:84:"Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy";}. gandini.annalice@gmail.com.
  • Zanardi E; U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy . elisa.zanardi@hsanmartino.it.
  • Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. giuseppe.fornarini@hsanmartino.it.
  • Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, 17100, Savona, Italy. saraelena89@hotmail.it.
Acta Biomed ; 94(S1): e2023232, 2023 08 22.
Article em En | MEDLINE | ID: mdl-37606060
ABSTRACT
Basal cell carcinoma (BCC) of the prostate is a very rare histologic variant of prostate cancer, of difficult diagnosis and uncertain prognosis. In fact, despite the frequency of prostate cancer, only 100 cases have been described in the literature, and most of the data derived from case reports. Because of the rarity of this disease, therapeutic options for these patients are scarce and no randomized trials are available. Here, we report the case of a 63-year-old man treated for a prostatic BCC (pBCC) that was challenging in terms of both diagnosis and treatment. We also performed a review of the literature to provide an overview of the therapeutic options for this rare tumor type and to better understand the role of molecular characterization in rare prostate cancer histologies. Given the rarity of pBCC worldwide, further collection of real-world data is needed to better understand the optimal diagnostic and therapeutic strategies for this rare disease.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Cutâneas / Carcinoma Basocelular Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Acta Biomed Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Cutâneas / Carcinoma Basocelular Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Acta Biomed Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália